de Abreu, J.D.M.F.; Azulay, R.S.; Rodrigues, V.; de Abreu, S.L.L.; da Glória Tavares, M.; Pinheiro, F.C.M.; de Oliveira Neto, C.P.; Andrade, C.; Facundo, A.; Sá, A.G.;
et al. Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2024, 12, 2542.
https://doi.org/10.3390/biomedicines12112542
AMA Style
de Abreu JDMF, Azulay RS, Rodrigues V, de Abreu SLL, da Glória Tavares M, Pinheiro FCM, de Oliveira Neto CP, Andrade C, Facundo A, Sá AG,
et al. Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease. Biomedicines. 2024; 12(11):2542.
https://doi.org/10.3390/biomedicines12112542
Chicago/Turabian Style
de Abreu, Joana D’Arc Matos França, Rossana Sousa Azulay, Vandilson Rodrigues, Sterffeson Lamare Lucena de Abreu, Maria da Glória Tavares, Flávia Coelho Mohana Pinheiro, Clariano Pires de Oliveira Neto, Caio Andrade, Alexandre Facundo, Adriana Guimarães Sá,
and et al. 2024. "Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease" Biomedicines 12, no. 11: 2542.
https://doi.org/10.3390/biomedicines12112542
APA Style
de Abreu, J. D. M. F., Azulay, R. S., Rodrigues, V., de Abreu, S. L. L., da Glória Tavares, M., Pinheiro, F. C. M., de Oliveira Neto, C. P., Andrade, C., Facundo, A., Sá, A. G., Azevedo, P. R., Almeida, A. G. P. d., Costa, D. C. d. A., Castro, R. S., Magalhães, M., Nascimento, G. C., Faria, M. d. S., & Ferreira, A. d. S. P.
(2024). Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease. Biomedicines, 12(11), 2542.
https://doi.org/10.3390/biomedicines12112542
